Clinical Trials
6 trialsNCT07609901 2026-05-27
PROTECT-Lynch
Radboud University Medical Center
Phase 3 Not yet recruiting
NCT02912559 2026-05-05
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT02000089 2025-10-09
CAPS5
Johns Hopkins University
Phase 3 Recruiting
NCT02813824 2025-07-08
AAS-Lynch
Assistance Publique - Hôpitaux de Paris
Phase 3 Active not recruiting
NCT04711434 2021-01-20
PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
Sun Yat-sen University
Phase 3 Unknown
NCT00566644 2013-07-10
Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome
National Cancer Institute (NCI)
Phase 3 Terminated